World leader in adaptogens
Kan Jang Andrographis SHA-10
KAN JANG Andrographis SHA-10
The original Swedish immune support formula used by millions
Kan Jang Andrographis SHA-10® is based on tailor-made combination of Andrographis and Eleuthero
(Eleutherococcus senticosus). Andrographis SHA-10 supports the natural defence mechanism and contributes to a healthy immune system, especially the upper respiratory tract. Eleuthero SHE-3 contributes to more mental and physical energy in exhaustion and fatigue and to maintain a healthy convalescence and immune system. Eleuthero has adaptogenic effect.
KAN JANG Andrographis SHA-10
Herbal Remedy (Denmark)
Against common cold
Contains the proprietary blend of andrographis paniculata SHA-10 extract and eleutherococcus senticosus SHE-3 extract
Kan Jang Andrographis tablets are sold in Denmark as a herbal remedy product which is equivalent to an WEU (Well-Established Use) international registration.
KAN ANDRO & KAN JANG Andrographis SHA-10
Herbal Food Supplement sold on Amazon in England, Germany, Italy, USA and soon in Sweden.
KAN JANG & KAN ANDRO Andrographis SHA-10
Kan Jang Andrographis with the proprietary combination of extracts derived from Andrographis paniculata and Eleuthero is one of the world’s most well-known brand as an early defense against sinusitis-like symptoms. Kan Jang is equipped with a multi-target effect, which includes the following properties: anti-inflammatory, immunomodulatory, antiviral and adaptogenic.
Kan Jang Andrographis provides multiple layers of defense:
• Alerts your body’s natural defenses
• Strengthens your immune system
• Relieves your early symptoms of a cold
• Energizes you
This means an early defense - more than 50% of upper respiratory tract infections will be prevented, which leads to fewer sick days. Kan Jang Andrographis gives a quick and direct action on sinusitis-like symptoms and was introduced in the Swedish market in 1978 by Georg Wikman, our funder.
Clinical Studies of Kan Jang / Andro SHA-10
All studies are product specific; and made on KAN JANG Andrographis SHA-10. The studies correspond to the daily dose of 4 capsules, except for one – the long-term study where only one capsule was used to prevent from common cold symptoms.
The EFSA registered health claims of KAN JANG Andrographis SHA-10 based on the tailor-made combination of Andrographis (Andrographis paniculata) and Eleuthero (Eleutherococcus senticosus) are: Andrographis supports the natural defence mechanism and contributes to a healthy immune system, especially the upper respiratory tract and soften respiratory troubles like coughs, sore
throats in a natural way. Eleuthero contributes to more mental and physical energy in exhaustion and fatigue and to maintain a healthy convalescence and immune system acting as immunomodulator by stimulating lymphocytes and increases the natural defences.
Overall, almost 2000 patients (with 240 children) were included in clinical, double-blind, randomized studies on the clinical efficacy of Kan Jang Andrographis. The investigators have shown on numerous occasions that Kan Jang is superior to placebo. The main benefits of using Kan Jang are shown in clinical studies that you can read more about below.
KAN JANG EFFECTIVE IN TREATING MILD COVID-19
Efficacy of Kan Jang® in patients with mild COVID-19: Interim analysis of a randomized, quadruple-blind, placebo-controlled trial. Ratiani L, Pachkoria E, Mamageishvili N, Shengelia R, Hovhannisyan A, Panossian A. Pharmaceuticals 2022, 15, 1013. https://doi.org/10.3390/ph15081013.
TREATS URTI AND REDUCES THE NUMBER OF SICK DAYS
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, quadruple-blind study. Narimanyan M, Jamalyan K, Balyan A, Barth A, Palm S, Wikman GK, Panossian A. Journal of Traditional and Complementary Medicine. 2021;11(6):552-562. doi: 10.1016/j.jtcme.2021.06.001.
REDUCES SICK LEAVE DAYS
A randomized, Double-Blind, Placebo-Controlled Multicenter Study of Kan Jang® Capsules in Patients with URTI Infection with the Primary Outcome of Sick Leave Days. Melchior J, Barth A, Hoheisel O, Palm S, Wikman G. Journal of Alternative Complementary & Integrative Medicine. 2021, May 07.
IN VITRO STUDY SHOWS ANTIVIRAL ACTIVITY
Antiviral Activity and Synergy of Herba Andrographidis and Radix Eleutherococci Preparations against SARS-CoV-2 Infected Vero E6 Human Primary Embryonic Kidney Epithelial Cells. Asea A, Kaur P, Wikman G. Journal of Alternative Complementary & Integrative Medicine. 2021 Feb 28. DOI:10.24966/ACIM-7562/100148.
NO RUNNY NOSE AND FASTER RECOVERY WITH KAN JANG
Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang® and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children. Spasov AA, Ostrovskij OV, Chernikov MV, Wikman G. Phytotherapy Research. 2004 Jan;18(1):47-53. doi: 10.1002/ptr.1359. https://pubmed.ncbi.nlm.nih.gov/14750201/
REDUCES DAYS OF SICK LEAVE ABD POST-INFLUENZA COMPLICATIONS
A randomized controlled study of Kan Jang versus Amantadine in the treatment of influenza in Volgograd. Kulichenko LL, Kireyeva LV, Malyshkina EN, Wikman G. Journal of Herbal Pharmacotherapy. 2003;3(1):77-93.
TREATS URTI AND SINUSITIS
A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Gabrielian ES, Shukarian AK, Goukasova GI, Chandanian GL, Panossian AG, Wikman G, Wagner H. Phytomedicine. 2002 Oct;9(7):589-97. doi: 10.1078/094471102321616391.
TREATS URTI AND SINUSITIS
Double blind placebo-controlled pilot and Phase III study of a standardised Andrographis paniculata Herba Nees extract fixed combination (Kan jang) in the treatment of uncomplicated upper respiratory tract infection. Melchior J, Spasov AA, Ostrovskij OV, Bulanov AE, Wikman G.
Phytomedicine. 2000 Oct;7(5):341-50. doi: 10.1016/S0944-7113(00)80053-7. https://pubmed.ncbi.nlm.nih.gov/11081985/
3-MONTH WINTER STUDY – KAN JANG PREVENTS COMMON COLD
Prevention of common colds with Andrographis paniculata dried extract. A pilot double blind trial.
Cáceres DD, Hancke JL, Burgos RA, Wikman GK. Phytomedicine. 1997 Jun;4(2):101-4. doi: 10.1016/S0944-7113(97)80051-7. https://pubmed.ncbi.nlm.nih.gov/23195395/
PREVENTS COMMON COLD AND REDUCES THE NUMBER OF SICK DAYS
Controlled clinicals study of standardized Andrographis paniculata extract in common cold - a pilot trial. Melchior J, Palm S, Wikman G. Phytomedicine. 1997 Feb;3(4):315-8. doi: 10.1016/S0944-7113(97)80002-5. https://pubmed.ncbi.nlm.nih.gov/23195187/
REDUCING COMMON COLD
Use of visual analogue scale measurements (VAS) to assess the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized double-blind placebo study. Cáceres DD, Hancke JL, Burgos RA, Sandberg F, Wikman GK. Phytomedicine. 1999 Oct;6(4):217-23. doi: 10.1016/S0944-7113(99)80012-9.
RESISTANCE TO COMMON COLD
A double-blind study with a new monodrug Kan Jang: Decrease of symptoms and improvement in the recovery from common colds. Hancke JL, Burgos R, Cáceres DD, Wikman G. Phytotherapy Research. 1995;9:559-562.